Bridged Piperazines and Piperidines as CCR1 Antagonists with Oral Activity in Models of Arthritis and Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|10|689-694

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.10, 2006-12, pp. : 689-694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCR1 and CCR2 Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1539-1552

Bentham Science Publishers

Access to resources Recommend Favorite

CCR1 antagonists in clinical development

By Pease James E   Horuk Richard  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 785-796

Informa Healthcare

Access to resources Recommend Favorite

Oral Agents in Multiple Sclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 14, Iss. 1, 2015-03 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Novel chemokine CCR1 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1355-1357

Informa Healthcare

Access to resources Recommend Favorite

CCR1 as a target for multiple myeloma

By Vallet Sonia   Anderson Kenneth C  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. : 1037-1047

Informa Healthcare

Access to resources Recommend Favorite